Novo Nordisk, Bluebird Targeting ‘Lifelong’ Gene Therapies

Duo Hopes To Leapfrog Gene Editing Hemophilia Rivals

 
• By Sten Stovall
  
Edit_Gene
Pact will use bluebird’s gene editing platform based on its megaTAL technology • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip